Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
rituximab (rituxan) (1 trial)
Lymphoma, B-Cell (Phase 1)
Meningeal Carcinomatosis (Phase 1)
Meningitis (Phase 1)
Trials (1 total)
Trial APIs (1 total)